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Background: The objectives of this study were to estimate the prevalence of thalassemia and to analyze the need
for public health services for migrant populations in different cities in Guangdong Province, China.
Methods: A cross-sectional survey was conducted in 21 cities of Guangdong Province. Twenty-three types of
a- and β-globin gene mutations were detected in a total of 14,230 pregnant women and 14,249 husbands.
Results: There was a 16.45% prevalence of thalassemia among the 28,479 individuals, and the prevalences of
α-, β-, and combined α-/β- thalassemia were 12.03%, 3.80%, and 0.63%, respectively. Compared with the native city
residents in the province, the migrants from within the province and the immigrants from outside the province had
lower prevalences of thalassemia, but the prevalence values were >11%.
Conclusions: The prevalence values for thalassemia gene mutations were high in all three population groups
studied in Guangdong Province. The results indicate that all segments of the Guangdong population should be
screened for thalassemia.
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Thalassemia is the most commonly inherited, recessive
single gene disease. Globally, approximately 7% of preg-
nant women carry β- or α zero-thalassemia, or other
hemoglobin disorders [1,2], which imposes an enormous
burden on families and society [3,4]. Thalassemia has
become a public health problem in Guangdong Province,
China. High prevalences of thalassemia are present in
Guangdong populations; 17.70% of pregnant women,
15.94% of their husbands, and 16.03% of neonates are
thalassemia carriers [5]. To prevent and control thalas-
semia major, the government of Guangdong has im-
plemented the Thalassemia Prenatal Prevention and
Control Program (TPPCP), which has been supported
by annual funding of 35 million RMB since 2011. In* Correspondence: pumpli587@sohu.com; 522276188@qq.com
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unless otherwise stated.2012, we used data obtained from this program and con-
ducted a baseline survey on the epidemiological status of
globin gene mutations in Guangdong.
As a developed area in China, Guangdong Province
has a large amount of immigration between cities and
between provinces, which imposes significant challenges
for the public health services. Most public health ser-
vices are only offered to native city residents who have a
registered household as part of the household registry
system. Little is known about the thalassemia prevalence
in this and in other types of registered household po-
pulations in different cities in Guandong Province. We
analyzed the α- and β-thalassemia prevalence in these
populations.Methods
The tested individuals were from one of three popula-
tions. The first population consisted of native city resi-
dents who were recorded in the local city household
register. They had primary social and health insurance
coverage and could obtain aid from the public health
program. The second population consisted of migrantshis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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residing in a household in another city in Guangdong
Province. These residents had no primary social and
health insurance coverage from the cities in which they
were currently residing, and had non-transferable health
insurance coverage from the cities or counties in which
they were registered. They also could not obtain aid
from the public health programs of the cities in which
they were currently residing. The third population con-
sisted of the immigrants from outside the province.
These individuals were not registered as living in a
household in Guangdong Province. They had no primary
social and health insurance coverage in Guangdong, did
not have transferable health coverage in the province in
which they were registered, and could not obtain aid
from the public health program in Guangdong.
This study used a cross-sectional survey design and
was performed using data from the baseline TPPCP sur-
vey of Guangdong. The survey was conducted in the 21
cities of Guangdong Province. One district or county
was randomly sampled from each city, and a total of 91
hospitals were selected according to the newborn deliv-
ery numbers in the sampled districts or counties. After
informed consent was obtained, 3 mL peripheral vein
blood (collected in an EDTA tube) was sampled from
each pregnant woman and her husband during the deliv-
ery period. The samples were temporarily placed into a
refrigerator at 4°C, and then mailed on ice by express
delivery to the genetics and metabolic diseases labora-
tory of Guangdong Women and Children Hospital for
further analysis. They arrived at the laboratory within
3 days, where they were analyzed for the globin gene
mutation. A total of 8,479 eligible blood samples were
tested, which included 14,230 pregnant women and
14,249 husbands. The results for the number of samples
from each city are presented in Table 1.
Detection of α- and β-globin gene mutations
Genomic DNA was extracted from all blood samples
using a Lab-Aid 820 automation system (Zee San
Biotech Company, Xiamen, Fujian, China). Twenty-three
mutations of the a- and β-globin genes were identified
using a Luminex 200 liquichip array system (R & D Sys-
tems Inc., Minneapolis, MN, USA) [6,7]. The system was
used throughout the process of probe design, the multi-
plex PCR, the attachment of probes to microspheres,
and hybridization and analysis. The 23 thalassemia mu-
tations included three α-globin gene deletions (i.e., the
Southeast Asian deletion [−SEA], the rightward deletion
[−α3.7], and the leftward deletion [−α4.2]). Three α-globin
gene point mutations were also analyzed (i.e., Hb Con-
stant Spring, Hb Quong Sze, and Hb Westmead). The 17
β-globin gene point mutations were on codons 41/42
(−TCTT), 654, −29 (A >G), −28 (A >G), codons 71/72(+A), codon 17 (A > T), codon 43 (G > T), Hb E (β26[B8]
Glu→ Lys, GAG >AAG or codon 26 [G >A]), codons 27/
28 (+C), codon 31 (−C), −32 (C > A), −30 (T > C), codons
14/15 (+G), IVS-I-1 (G > T), IVS-I-5 (G > T), Int, and Cap.Statistical analysis
We used the “vcd” and “car” program packages of R Ver-
sion 3.0.1 statistical software (May 16, 2013, copyright
2013, R Foundation for Statistical Computing, Vienna,
Austria) to analyze the data. We calculated the values
for thalassemia carrier prevalence, with 95% confidence
intervals (95% CIs), for the different household registry-
based populations for all of the cities in Guangdong.
The differences between prevalence values were com-
pared using the chi-square test or the Mantel–Haenszel
chi-square test. A thalassemia carrier was defined as an
individual who carried any one of the 23 types of α-
and/or β-globin gene mutations.Results
Blood samples were collected from a total of 28,479 in-
dividuals; 71.45% (20,349/28,479) were native residents
of the city in which they resided, 19.83% (5,647/28,479)
of them were migrants from another city within the
province, and 8.72% (2,483/28,479) of them were immi-
grants from other provinces.
The results for the prevalence values for the different
thalassemia genotypes are presented in Table 2. The
overall prevalence of thalassemia carriers was 16.45%.
The prevalence of α-, β-, and combined α-/β- thalas-
semia carriers was 12.03%, 3.80%, and 0.63%, respect-
ively. The specific prevalence values for the different
clinical forms of the disease were also calculated. The
prevalence of α+-thalassemia was 5.71%, α0-thalassemia
was 6.12%, hemoglobin H (HbH) disease was 0.20%, β-
thalassemia minor (β0/βN or β+/βN) was 3.78%, β-
thalassemia intermedia was 0.01%, α0- or α+-thalassemia
with β-thalassemia minor was 0.60%, HbH disease with
β-thalassemia minor was 0.02%, α0-thalassemia with β-
thalassemia intermedia carrier was 0.004%. The top
three genotypes of α-thalassemia were –SEA/αα, α3.7α/
αα, and α4.2α/αα. The top three genotypes of β-
thalassemia were β41–42/βN, β654/βN, and β−28/βN.
The results for thalassemia carrier prevalence in differ-
ent population groups are presented in Table 1. The
values for thalassemia carrier prevalence for the native
city residents, the migrants from within the province,
and the immigrants from outside the province were
17.16% (3491/20349), 16.04% (906/5647), and 11.64%
(289/2483), respectively. Compared with the native city
residents, the migrants from within the province and the
immigrants from outside the province had a lower
prevalence of thalassemia carriers, but the prevalence
Table 1 The prevalence (%) of thalassemia carriers among different household register population of cities of Guangdong, China
Sampled cites
of Guangdong


























Chaozhou 737 84 11.40 48 4 8.33 202 15 7.43 987 103 10.44 χ2 = 2.91,
Raoping (9.11, 13.68) (0.55, 16.11) (3.83, 11.02) (8.54, 12.33) P > 0.05
Jieyang 1318 135 10.24 108 12 11.11 54 5 9.26 1480 152 10.27 χ2 = 0.14,
Puning (8.61, 11.87) (5.21, 17.01) (1.57, 16.95) (8.73, 11.81) P > 0.05
Shantou 620 46 7.42 800 76 9.50 81 9 11.11 1501 131 8.73 χ2 = 2.51,
Jinping (5.37, 9.47) (7.48, 11.52) (4.30, 17.92) (7.31, 10.15) P > 0.05
Shanwei 1118 123 11.00 60 9 15.00 51 4 7.84 1229 136 11.07 χ2 = 1.49,
Haifeng (9.18, 12.83) (6.01, 23.99) (0.50, 15.18) (9.32, 12.81) P > 0.05
Total 3793 388 10.23 1016 101 9.94 388 33 8.51 5197 522 10.04 χ2 = 1.17,
(9.27, 11.19) (8.11, 11.77) (5.74, 11.27) (9.23, 10.86) P > 0.05
Montain Area
Heyuan 1346 265 19.69 136 29 21.32 91 15 16.48 1573 309 19.64 χ2 = 0.82,
District (17.57, 21.80) (14.47, 28.17) (8.90, 24.07) (17.69, 21.60) P > 0.05
Meizhou 934 199 21.31 26 5 19.23 42 8 19.05 1002 212 21.16 χ2 = 0.18,
Xingning (18.69, 23.92) (4.16, 34.30) (7.23, 30.86) (18.64, 23.67) P > 0.05
Qingyuan 1165 237 20.34 88 15 17.05 92 16 17.39 1345 268 19.93 χ2 = 0.96,
Yingde (18.04, 22.64) (9.23, 24.86) (9.69, 25.10) (17.80, 22.05) P > 0.05
Shaoguan 981 185 18.86 164 20 12.20 139 17 12.23 1284 222 17.29 χ2 = 7.15,
District (16.42, 21.29) (7.21, 17.18) (6.81, 17.65) (15.23, 19.35) P < 0.05
Yunfu 1048 265 25.29 295 67 22.71 95 11 11.58 1438 343 23.85 χ2 = 9.28,
Luoding (22.67, 27.90) (17.96, 27.47) (5.18, 17.98) (21.66, 26.04) P < 0.01
Total 5474 1151 21.03 709 136 19.18 459 67 14.60 6642 1354 20.39 χ2 = 11.50,
(19.95, 22.10) (16.30, 22.07) (11.38, 17.81) (19.42, 21.35) P < 0.05
The Pearl River Delta
Dongguan 959 130 13.56 412 76 18.45 111 6 5.41 1482 212 14.30 χ2 = 13.38,
District (11.40, 15.71) (14.72, 22.17) (1.22, 9.59) (12.53, 16.08) P < 0.01
Foshan 847 123 14.52 466 93 19.96 100 11 11.00 1413 227 16.07 χ2 = 8.63,
(16.35, 23.57) (4.90, 17.10) (14.16, 17.97) P < 0.05Nanhai (12.16, 16.88)
Guangzhou 756 93 12.30 375 64 17.07 96 9 9.38 1227 166 13.53 χ2 = 6.40,
Panyu (9.97, 14.63) (13.28, 20.86) (3.57, 15.18) (11.62, 15.43) P < 0.05


















Table 1 The prevalence (%) of thalassemia carriers among different household register population of cities of Guangdong, China (Continued)
District (17.24, 22.57) (10.75, 16.74) (2.86, 12.39) (14.92, 18.72) P < 0.001
Jiangmen 1282 231 18.02 121 20 16.53 47 5 10.64 1450 256 17.66 χ2 = 1.81,
Xinhui (15.93, 20.11) (9.94, 23.11) (1.87, 19.41) (15.70, 19.61) P > 0.05
Shenzhen 194 29 14.95 913 149 16.32 174 14 8.05 1281 192 14.99 χ2 = 7.85,
Baoan (9.96, 19.94) (13.93, 18.70) (4.02, 12.07) (13.04, 16.93) P < 0.05
Zhaoqing 1143 215 18.81 191 46 24.08 85 15 17.65 1419 276 19.45 χ2 = 3.09,
Sihui (16.56, 21.06) (18.05, 30.12) (9.58, 25.71) (17.40, 21.50) P > 0.05
Zhongshan 705 85 12.06 174 32 18.39 569 65 11.42 1448 182 12.57 χ2 = 6.21,
District (9.67, 14.45) (12.66, 24.12) (8.82, 14.02) (10.87, 14.27) P < 0.05
Zhuhai 675 115 17.04 382 72 18.85 106 15 14.15 1163 202 17.37 χ2 = 1.40,
Doumen (14.22, 19.86) (14.95, 22.75) (7.55, 20.75) (15.20, 19.54) P > 0.05
Total 7415 1191 16.06 3536 621 17.56 1406 149 10.60 12357 1961 15.87 χ2 = 37.06,
(15.23, 16.89) (16.31, 18.81) (9.00, 12.20) (15.23, 16.51) P < 0.001
West Area
Maoming 1292 240 18.58 47 5 10.64 75 10 13.33 1414 255 18.03 χ2 = 3.1,
Huazhou (16.47, 20.69) (1.87, 19.41) (5.68, 20.99) (16.04, 20.03) P > 0.05
Yangjiang 1393 355 25.48 74 4 5.41 54 8 14.81 1521 367 24.13 χ2 = 18.13,
Yangchun (23.21, 27.76) (0.28, 10.53) (5.39, 24.24) (21.99, 26.27) P < 0.001
Zhanjiang 982 166 16.90 265 39 14.72 101 22 21.78 1348 227 16.84 χ2 = 2.62,
Lianjiang (14.57, 19.24) (10.47, 18.96) (13.77, 29.79) (14.85, 18.83) P > 0.05
Total 3667 761 20.75 386 48 12.44 230 40 17.39 4283 849 19.82 χ2 = 16.11,
(19.45, 22.06) (9.16, 15.71) (12.52, 22.26) (18.63, 21.01) P < 0.001
All Guangdong 20349 3491 17.16 5647 906 16.04 2483 289 11.64 28479 4686 16.45 χ2 = 49.85,
(16.64, 17.67) (15.09, 17.00) (10.38, 12.89) (16.03, 16.88) P < 0.001


















Table 2 The prevalence (%) of different genotypes of thalassemia among pregnant coupes of Guangdong, China (n = 28479)
Individuals only with α-thalassemia Individuals only with β-thalassemia Individuals combined α-/β- thalassemia carriers





























α3.7α/αα 911 3.20 (3.00,
3.40)
β41–42/βN (β0/βN) 415 1.46 (1.32,
1.60)
–SEA/αα, β654/βN





α4.2α/αα 313 1.10 (0.98,
1.22)
β654/βN (β0/βN) 281 0.99 (0.87,
1.10)
α3.7/αα, β41–42/βN





αWSα/αα 239 0.84 (0.73,
0.94)
β17/βN (β0/βN) 95 0.33 (0.27,
0.40)
α3.7/αα, β−28/βN





αCSα/αα 83 0.29 (0.23,
0.35)
β71–72/βN (β0/βN) 24 0.08 (0.05,
0.12)
–SEA/αα, β−28/βN





αQSα/αα 47 0.17 (0.12,
0.21)
β27–28/βN (β0/βN) 19 0.07 (0.04,
0.10)
α3.7/αα, β654/βN





α3.7α/α4.2α 9 0.03 (0.01,
0.05)
β14–15/βN (β0/βN) 10 0.04 (0.01,
0.06)
αWSα/αα, β41–42/βN (α+,





α3.7α/α3.7α 8 0.03 (0.01,
0.05)
β43/βN (β0/βN) 6 0.02 (0.00,
0.04)
α4.2/αα, β41–42/βN





α3.7α/αWSα 5 0.02 (0.00,
0.03)
βIVS-1/βN (β0/βN) 6 0.02 (0.00,
0.04)
–SEA/αα, β17/βN (α0,





α3.7α/αCSα 3 0.01 (0.00,
0.02)
βInt/βN (β0/βN) 1 0.00 (0.00,
0.01)
–SEA/αα, βE/βN (α0,





α3.7α/αQSα 3 0.01 (0.00,
0.02)
β−28/βN (β+/βN) 155 0.54 (0.46,
0.63)
α3.7/αα, β17/βN (α+,





α4.2α/αWSα 3 0.01 (0.00,
0.02)
βE/ βN (β+/βN) 24 0.08 (0.05,
0.12)
α4.2/αα, β−28/βN





α4.2α/αCSα 1 0.00 (0.00,
0.01)
βCap/βN (β+/βN) 23 0.08 (0.05,
0.11)
αCSα/αα, β41–42/βN





α4.2α/αQSα 1 0.00 (0.00,
0.01)
β−29/βN (β+/βN) 17 0.06 (0.03,
0.09)
α3.7/αα, β71–72/βN










βIVS-5/βN (β+/βN) 1 0.00 (0.00,
0.01)
α4.2/αα, β17/βN (α+,























β−28/βE (β+/β+) 1 0.00 (0.00,
0.01)
–SEA/α3.7, β654/βN
(HbH, β0/βN) 2 0.01 (0.00,0.02)
–SEA/α3.7 33 0.12 (0.08,
0.16)
β41–42/βCap (β0/β+) 1 0.00 (0.00,
0.01)
–SEA/αCSα, β41–42/βN
(HbH, β0/βN) 2 0.01 (0.00,0.02)
–SEA/α4.2 15 0.05 (0.03,
0.08)
β41–42/βE (β0/β+) 1 0.00 (0.00,
0.01)
–SEA/αα, β71–72/βN


















Table 2 The prevalence (%) of different genotypes of thalassemia among pregnant coupes of Guangdong, China (n = 28479) (Continued)
–SEA/αWSα 5 0.02
(0.00, 0.03)
β−28/β17 (β+/β0) 1 0.00 (0.00,
0.01)
α4.2/αα, βE/βN
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http://www.biomedcentral.com/1471-2458/14/905was >11%. The difference between these prevalence
values was significant (χ2 = 49.85, P < 0.001).
For thalassemia carrier prevalence in the different
areas of Guangdong Province, the differences between
the different household registry populations were vari-
able. Prevalence values were not significantly different
(P > 0.05) between the four cities in the east area. In the
mountain area, two of five cities had a significantly dif-
ferent prevalence (P < 0.05). In the Pearl River delta area,
six of nine cities had a significantly different prevalence
(P < 0.05), and in seven cities migrants from within the
province had a higher prevalence of thalassemia carriers.
In the west area, one of three cities had a significantly
different prevalence value (P < 0.05).
Discussion
Our results indicated that thalassemia is a serious public
health problem in Guangdong. The average prevalence
of thalassemia in the Guangdong population was 16.45%,
and the prevalence of α-, β-, and combined α-/β-
thalassemia was 12.03%, 3.80%, and 0.63%, respectively.
These values were higher than values previously re-
ported for prevalence for Guangdong Province [8,9].
Our data also indicated that the native city resident
population in the province, the migrant population
from within the province, and the immigrant popula-
tion from outside the province also have had a high
prevalence of thalassemia. In some surveyed cities, the
thalassemia prevalence in the migrant population from
within the province was higher compared with the
prevalence in native city residents in the province. In
all targeted populations, the native city residents and
the immigrants from other cities of the same or other
provinces belong to the same ethnic group, and the
finding that there were similar prevalences of thalas-
semia mutations supports this observation.
Worldwide, 56,000 conceptions per year have a major
thalassemia disorder. Approximately 30,000 of these are
affected by β-thalassemia major, and 3,500 succumb
from hydrops fetalis syndrome during the perinatal
period [1]. Interestingly, in Guangdong, thalassemia also
causes a significant economic and disease burden. Thal-
assemias were originally characteristic of the tropics and
subtropics, but are now common worldwide because of
migration [10,11]. Because thalassemia can be controlled
in a cost-effective manner using programs that integrate
treatment with carrier detection and genetic counseling,
the World Health Organization has recommended glo-
bal development of these services [12]. Many countries
and areas have implemented antenatal or premarital
thalassemia screening programs [13,14]. Since the 1990s,
some hospitals have delivered voluntary antenatal thalas-
semia screening and counseling services in Guangdong
Province [14]. In 2011, the Guangdong governmentinitiated an antenatal thalassemia prevention and control
program, which includes 35 million RMB per year in fi-
nancial support.
Because of the household registry arrangement and re-
source limitations, public health services for thalassemia
prevention have only been offered to native city resi-
dents in the province. However, our results indicate that
all segments of the Guangdong population should be
screened for thalassemia. The migrants from within the
province and the immigrants from outside the province
accounted for nearly 30% of the total population in
many cities in Guandong, which could affect the out-
comes of thalassemia prevention programs and challenge
the public health service system of Guangdong. The re-
sults of a Thalassemia International Federation study in-
dicated that countries with a strong prevention and
treatment program are well prepared to face the prob-
lem of hemoglobinopathy gene migration into the popu-
lation [14].
Previously, the thalassemia prevalence reported for
Guangdong Province was approximately 5–11% [9,10].
The differences between these figures and our results
were mainly owing to differences in areas selected
for sampling, the populations examined, the detection
methods, and the spectra of globin gene mutations ex-
amined. We sampled a greater number of cities and
populations. We used the more sensitive liquichip array
system for detection of globin gene mutation and found
23 types of globin gene mutations. A higher prevalence
of thalassemia carriers (24.51%) has been reported for
Guangxi Province [15]. Bangalore et al. reported that the
prevalence of the β-thalassemia trait among pregnant
women was 8.5%, [16] which was also higher than that
of Guangdong, but these results were estimated from
data from an antenatal care clinic.
The analysis of our data revealed that 0.22% (64/
28479) of individuals were carriers of HbH disease,
which could be a serious health problem for pregnant
couples. The incidence of HbH disease has been re-
ported to be 0.43% in Guangxi Province [15]. HbH dis-
ease is predominantly seen in South East Asia, the
Middle East, and the Mediterranean [17].
There are some limitations that must be taken into
consideration in our study. We only sampled one county
or district in each city, so the results might not represent
the true prevalence of thalassemia carriers in the popula-
tion of that city. We also did not consider the duration
of residence of the migrant populations.
Conclusion
The prevalence of thalassemia gene mutations was high
in native city resident populations in Guangdong
Province, the migrant populations from within the
province, and the immigrant populations from outside the
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http://www.biomedcentral.com/1471-2458/14/905province. The results indicate that all segments of the
Guangdong population should be screened for thalas-
semia. The effectiveness of thalassemia prevention pro-
grams might be improved if the entire population in
Guangdong Province were included. Policy makers should
establish a strategy that allows affordable thalassemia
prevention public health programs to be provided to
inter-city and inter-province migrant populations in
Guangdong Province.
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